Original questions are transcribed from the public-domain edition. Credit: Wellcome Collection; original supplied by Royal College of Physicians, London. Source and public-domain rights statement.
The historical standard used below is the British Pharmacopoeia by the General Medical Council (1867). A contemporary July publication notice records official publication notices dated 14 June 1867, before this December examination. Later reprints containing the additions of 1874 must be distinguished from this original issue.[ref] These are explanations of historical materia medica, with present physiology identified separately where it changes the interpretation.
Original question.
What are the most commonly used preparations of Iron, and in what form does the metal exist in them ?
The main distinction is between metallic iron, iron(II) preparations, iron(III) preparations, and mixed iron oxides. The old prefixes “proto-” and “per-” ordinarily distinguish the lower and higher oxidation states here. “Peroxide of iron” means the historical iron(III) oxide preparation, not a modern peroxide containing an oxygen–oxygen bond.
The principal medicinal preparations can be grouped by the chemical form supplied:
These identifications follow the historical monographs, rather than the names of present commercial supplements.[ref] A green iron(II) sulfate solution gives the characteristic blue reaction with potassium ferricyanide, whereas the higher iron solutions give blue with potassium ferrocyanide. Those diagnostic reactions explain why the official tests distinguish the two oxidation states; the historical colour test alone does not establish every detail of a complex preparation's composition.
Original question.
How is Sulphate of Quinia prepared, and what are the tests of its purity given in the British Pharmacopœia ?
Prepare quinine sulfate by acidic extraction of cinchona bark, alkaline precipitation of the quinine base, conversion into the sulfate, and purification by crystallization. “Quinia” is the historical name for quinine.
The 1867 process starts with one pound of yellow cinchona bark in coarse powder, three fluid ounces of hydrochloric acid, four pints of solution of sodium hydroxide, and sufficient distilled water and diluted sulfuric acid. The hydrochloric acid is diluted with ten pints of distilled water. The bark is first moistened with diluted sulfuric acid, macerated for twenty-four hours with occasional stirring, and then exhausted in a percolator with the diluted hydrochloric acid. The historical endpoint is disappearance of the bitter character of the emerging liquid. This describes the period's test, not an instruction to taste an unidentified medicinal material.[ref]
The soluble alkaloid salts enter the percolate. Adding solution of sodium hydroxide liberates the much less water-soluble quinine base. After settling, the liquid is decanted and the precipitate collected on a filter and washed with cold distilled water until the washings cease to be coloured. The precipitate is then treated warm with distilled water and diluted sulfuric acid, added gradually to obtain a neutral liquid with nearly all the precipitate dissolved. The hot solution is filtered through paper, the filter washed with distilled water, and the filtrate concentrated until a surface film appears. It is then set aside for crystallization; the crystals are dried on filter paper without applied heat. This is a separation of a naturally occurring alkaloid, not a synthesis of the quinine skeleton.
Writing for the quinine base, the central changes are:
(1)
The successive changes in solubility explain the apparatus: a percolator washes soluble salts out of the powder; a filter retains the liberated base; a heated porcelain vessel dissolves the crude base as its sulfate; cooling then recovers the less soluble crystals. Other cinchona alkaloids can accompany the product, which is why appearance and bitterness are insufficient evidence of purity.
The 1867 “Characters and Tests” combine identity and purity checks. They must be read as a group:
The historical quantity and endpoint requirements belong to the 1867 monograph.[ref] Its formula represents the then-described heptahydrate; the current “Quinine sulfate” instead specifies a dihydrate and modern tests for related cinchona alkaloids. The modern specification explains that distinction; the exam's historical tests remain those listed above.[ref]
Original question.
What parts of the following plants are directed by the British Pharmacopœia to be used; viz., Sambucus, Scilla, Rosa Gallica, Pterocarpus, Physostigma venenosum, Theobroma Cacoa, Croton Tiglium, Taraxacum.
The required sequence is fresh flowers; sliced and dried bulb; unexpanded petals; heartwood; seeds; expressed seed fat; expressed seed oil; and fresh and dried root. The plant organ, its state, and the actual official material must all be specified.
The names in the paper sometimes use the shorter terminology of the first British Pharmacopoeia, whereas the 1867 edition explicitly renamed many entries to identify the medicinal organ. Its alteration list, for example, maps Sambucus to Sambuci flores, Pterocarpus to Pterocarpi lignum, and Taraxacum to Taraxaci radix.[ref] That is a nomenclature change, not permission to choose any part of the named plant.
Original question.
What is the active agent in the various means of producing blisters on the skin, and by what physiological processes do they act beneficially ?
Ordinary cantharides blisters owe their activity to cantharidin; other blistering methods act through different chemical irritants or through physical injury. There is no single substance common to every way of raising a blister.
In the standard historical preparations, the dried blister beetle supplies cantharidin. A plaster, blistering paper, blistering liquid, or cantharides vinegar is a different vehicle for delivering the same vesicant to the skin. Extracting the beetle into a liquid does not make the solvent the specific active principle. The 1867 British Pharmacopoeia includes Emplastrum cantharidis, Charta epispastica, Liquor epispasticus and Acetum cantharidis.[ref]
Other historical means need separate explanations. Moist mustard develops an irritant volatile product, principally allyl isothiocyanate from black mustard; its usual intended effect is reddening, with prolonged exposure capable of more destructive injury. This differs from the fixed mustard seed oil: the irritant volatile product develops after moistening the powdered seeds.[ref] Strong Ammonia acts as an alkaline irritant. Croton oil can produce an inflammatory and pustular eruption, which is not the same lesion as a clean cantharides blister. A sufficiently hot object or hot liquid raises a blister through thermal damage, without a medicinal active molecule. These differences matter because erythema, a fluid-filled blister, a pustule, and tissue destruction are not interchangeable endpoints.
For cantharidin, the modern tissue explanation involves loss of adhesion between epidermal cells, including disruption of desmosomes, with separation within the epidermis and accumulation of fluid. The blister is therefore a local lesion of cell adhesion accompanied by inflammation, rather than a pocket containing disease drawn from a remote organ. The FDA review describes this acantholysis and distinguishes it from the incompletely understood mechanism of clinical benefit in a particular modern indication.[ref]
A nineteenth-century answer would usually describe two supposed routes to benefit:
  • Counterirritation. A new superficial irritation was believed to relieve a deeper painful or inflamed part by altering nervous activity and the distribution of blood. A physiologically intelligible component is that input from sensory nerves can change pain processing and reflex output. That does not establish the stronger historical claim that creating an artificial inflammation cures an unrelated internal inflammation.
  • Serous drainage or “depletion”. Fluid escaping from the raised blister was thought to remove fluid from the circulation and reduce local fullness. Fluid does indeed leave damaged blood vessels and collect in the blister, but the observation alone does not demonstrate beneficial selective removal of a disease-producing substance. Maintaining a draining sore was a historical practice, not a consequence required by current physiology.
Thus the demonstrable processes are local injury, inflammation, fluid exudation, and sensory stimulation; the broad historical claims of remote benefit require separate evidence. Current approved topical cantharidin use for molluscum contagiosum does not validate nineteenth-century blistering for diseases of internal organs. The modern label explicitly states that the mechanism of action in molluscum contagiosum is unknown and documents local skin reactions.[ref]
Original question.
‘A remedy must be absorbed before it can exert any remote action on the Animal Economy.’
Is this true ? Illustrate the statement.
The assertion is too absolute: a remedy can cause a distant response through a reflex or another intervening physiological change without first being absorbed into the blood. It is substantially right for the direct action of a circulating drug on a distant target, but does not describe every remote effect of treatment.
Three mechanisms should be distinguished:
The distinction is between transport of the medicinal substance and transmission of its consequences. A reflex transmits activity in neurons; a locally acting intestinal agent changes a physical condition; a circulating drug delivers molecules to its distant target. The same remedy may combine these routes, and an apparently rapid effect does not by itself settle which route caused it.
A useful experimental design would therefore compare remote responses with measurements of the agent in blood, and would test the proposed neural pathway separately. In an appropriate physiological preparation, recording the response while interrupting a relevant afferent pathway can test whether that pathway is necessary; preserving the circulation while interrupting nerve conduction distinguishes neural transmission from vascular transport. Conversely, a remote effect after vascular transfer supports a circulating agent, provided contamination and other transferred mediators are controlled. Failure to detect a drug is only as strong as the analytical detection limit.
Absorption is one route to remote action, not a universal prerequisite for every distant physiological consequence. The historical language “animal economy” means the functioning organism; it should not conceal the distinction between a direct pharmacological effect and a secondary physiological response.
Original question.
Describe the articles of Materia Medica placed on the table and labelled A, B, C, D, E.
TODO: specimens A–E are missing; their identities and observed characters cannot be recovered from the paper. The scanned volume supplies no description, illustration, label key, or preserved samples for those five articles. Each identification and its specimen-specific description therefore remains incomplete.
A valid examination of the missing materials would first record each label separately and describe the actual material: whole or powdered form; size and shape; external and cut surfaces; texture and fracture; and any diagnostic plant organ or animal structure. For a botanical material, microscopy could distinguish bark, wood, root, leaf and seed tissues, with suitable reference material and the historical pharmacopoeia definition used for comparison. A putative chemical preparation would instead require appropriate solubility and reagent tests. No colour, smell, section, chemical reaction, botanical origin or medicinal constituent is asserted for an unseen sample. Historical descriptions involving tasting are documentary evidence, not a method to apply to unknown potentially poisonous materials.

Ancestors (9)

  1. Second examination
  2. 1867
  3. Past exam of the medicine course of the University of Oxford
  4. Medicine course of the University of Oxford
  5. Undergraduate course of the University of Oxford
  6. Course of the University of Oxford
  7. University of Oxford
  8. List of universities
  9. Home

Incoming links (1)

View article source

Discussion (0) New discussion

There are no discussions about this article yet.

Articles by others on the same topic (0)

There are currently no matching articles.
See all articles in the same topic Create my own version